Ftse Mib
34.790,35
0,38%
DAX
18.741,07
-0,08%
S&P 500
5.227,24
0,09%
NASDAQ
16.391,77
0,31%
Bitcoin
62.924,52
2,40%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Synlogic Inc (SYBX) Synlogic Inc (SYBX) Notizie

SYBX

Synlogic (SYBX)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SYBX
DataOraFonteTitoloSimboloCompagnia
19/03/202412:00GlobeNewswire Inc.Synlogic Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:SYBXSynlogic Inc
22/02/202422:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:SYBXSynlogic Inc
20/02/202423:05Edgar (US Regulatory)Form 8-A12B - Registration of securities [Section 12(b)]NASDAQ:SYBXSynlogic Inc
20/02/202418:15GlobeNewswire Inc.Synlogic Adopts Limited Duration Stockholders Rights PlanNASDAQ:SYBXSynlogic Inc
16/02/202422:54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
16/02/202422:44Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:SYBXSynlogic Inc
14/02/202421:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:SYBXSynlogic Inc
08/02/202422:15GlobeNewswire Inc.Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
02/02/202418:00GlobeNewswire Inc.Synlogic Announces Publication of Preclinical and Clinical Data for SYNB1353 as a Potential Treatment for Classical HomocystinuriaNASDAQ:SYBXSynlogic Inc
04/01/202422:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:SYBXSynlogic Inc
04/01/202413:00GlobeNewswire Inc.Synlogic Provides Corporate Update and Outlook for 2024NASDAQ:SYBXSynlogic Inc
27/12/202313:00GlobeNewswire Inc.Synlogic Announces Contract with the Air Force Research LabNASDAQ:SYBXSynlogic Inc
07/12/202313:00GlobeNewswire Inc.Synlogic Announces Abstract Accepted for Poster Presentation at the International Conference on Microbiome Engineering 2023NASDAQ:SYBXSynlogic Inc
09/11/202313:00GlobeNewswire Inc.Synlogic Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:SYBXSynlogic Inc
09/11/202312:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:SYBXSynlogic Inc
07/11/202313:00GlobeNewswire Inc.Synlogic Achieves Research Milestone and Earns $2.5 Million Milestone Payment from Roche CollaborationNASDAQ:SYBXSynlogic Inc
13/10/202322:17Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:SYBXSynlogic Inc
03/10/202322:15GlobeNewswire Inc.Synlogic Announces Closing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
02/10/202323:05Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:SYBXSynlogic Inc
29/09/202313:00GlobeNewswire Inc.Synlogic Announces Pricing of $21.0 Million Underwritten Public OfferingNASDAQ:SYBXSynlogic Inc
29/09/202306:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SYBXSynlogic Inc
29/09/202303:43Edgar (US Regulatory)Form S-1MEF - Registration adding securities to prior Form S-1 registration [Rule 462(b)]NASDAQ:SYBXSynlogic Inc
28/09/202317:15GlobeNewswire Inc.Synlogic Announces Publication of Synpheny-1 Phase 2 Study of Synthetic Biotic for Phenylketonuria in Nature MetabolismNASDAQ:SYBXSynlogic Inc
28/09/202314:39Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:SYBXSynlogic Inc
27/09/202318:30GlobeNewswire Inc.Synlogic Announces Reverse Stock SplitNASDAQ:SYBXSynlogic Inc
21/09/202313:00GlobeNewswire Inc.Synlogic to Participate in Chardan’s Genetic Medicines ConferenceNASDAQ:SYBXSynlogic Inc
19/09/202317:00GlobeNewswire Inc.Synlogic Announces CEO Aoife Brennan Named to PharmaVoice 100NASDAQ:SYBXSynlogic Inc
08/09/202322:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:SYBXSynlogic Inc
01/09/202314:00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:SYBXSynlogic Inc
21/08/202323:15Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:SYBXSynlogic Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:SYBX

La tua Cronologia

USOTC
DFYFF
Definity Financial (PK)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network